MSB 4.07% $1.15 mesoblast limited

Two years to determine any adverse events and Secondary Outcome...

  1. 3,804 Posts.
    lightbulb Created with Sketch. 359
    Two years to determine any adverse events and Secondary Outcome relating to Opioid Usage (24 months). 12 months and a bit for low back pain results.

    Primary Completion 24 months.
    Primary Outcome Measures
    1. Mean Change From Baseline in Daily Average Low Back Pain at 12 Months Post-treatment Based on Visual Analog Scale (VAS) Score
      Low back pain intensity will be measured using a VAS ranging from 0-100 millimeter (mm). A score of 0 represents no pain and 100 represents worst possible pain.
      [Time Frame: Baseline and Month 12]
    2. Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)
      [Time Frame: Up to Month 24]


    Last edited by vasilios: Today, 09:45
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.